# Form 4 code C: Conversion of derivative security

Canonical: https://sec-api.dev/form-4-transaction-codes/c

> Conversion of a derivative security, for example preferred stock converted into common stock. Changes the form of the holding rather than adding exposure.

Q3 2026: 903 non-derivative and 854 derivative rows.

| Date | Issuer | Insider | Shares | Price | Filing |
| --- | --- | --- | --- | --- | --- |
| 2026-09-30 | PINTEREST, INC. | Silbermann Benjamin | 46875.0 | 0.0 | https://www.sec.gov/Archives/edgar/data/1506293/000177391426000031/0001773914-26-000031-index.htm |
| 2026-09-29 | Cerebras Systems Inc. | Mallick Dhiraj | 276000.0 | 0.0 | https://www.sec.gov/Archives/edgar/data/2021728/000162828026064042/0001628280-26-064042-index.htm |
| 2026-09-29 | PINTEREST, INC. | Silbermann Benjamin | 46875.0 | 0.0 | https://www.sec.gov/Archives/edgar/data/1506293/000177391426000031/0001773914-26-000031-index.htm |
| 2026-09-28 | Workday, Inc. | DUFFIELD DAVID A | 98971.0 | 0.0 | https://www.sec.gov/Archives/edgar/data/1327811/000093807126000061/0000938071-26-000061-index.htm |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | OrbiMed Genesis GP LLC / OrbiMed Israel GP II, L.P. / OrbiMed Capital GP VII LLC / OrbiMed Advisors Israel II Ltd / ORBIMED ADVISORS LLC | 564187.0 |  | https://www.sec.gov/Archives/edgar/data/1802369/000094787126000910/0000947871-26-000910-index.htm |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | OrbiMed Genesis GP LLC / OrbiMed Israel GP II, L.P. / OrbiMed Capital GP VII LLC / OrbiMed Advisors Israel II Ltd / ORBIMED ADVISORS LLC | 10690530.0 |  | https://www.sec.gov/Archives/edgar/data/1802369/000094787126000910/0000947871-26-000910-index.htm |

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up